{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:49:41Z","timestamp":1771663781552,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/hr.2016.120","type":"journal-article","created":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T06:13:21Z","timestamp":1472710401000},"page":"203-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan"],"prefix":"10.1038","volume":"40","author":[{"given":"Ai","family":"Ibaraki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Iura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tsuchihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"BFhr2016120_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S . The Japanese Society of Hypertension committee for guidelines for the management of hypertension. Hypertens Res 2014; 37: 253\u2013392.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/hr.2012.216","volume":"36","author":"T Kohro","year":"2013","unstructured":"Kohro T, Yamazaki T, Sato H, Ohe K, Nagai R . The impact of a change in hypertension management guidelines on diuretic use in Japan: trends in antihypertensive drug prescriptions from 2005 to 2011. Hypertens Res 2013; 36: 559\u2013563.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/10641960802621317","volume":"31","author":"Y Ohta","year":"2009","unstructured":"Ohta Y, Tsuchihashi T, Morinaga Y, Onaka U, Ueno M . Blood pressure and lipid control status in Japanese hypertensive patients. Clin Exp Hypertens 2009; 31: 298\u2013305.","journal-title":"Clin Exp Hypertens"},{"key":"BFhr2016120_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.114.04262","volume":"64","author":"K Kario","year":"2014","unstructured":"Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, Kobayashi F, Shimada K . Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy. Primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension 2014; 64: 989\u2013996.","journal-title":"Hypertension"},{"key":"BFhr2016120_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/hr.2015.3","volume":"38","author":"H Rakugi","year":"2015","unstructured":"Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, Shirakawa M, Azuma K, Fujita KP . Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg. Hypertens Res 2015; 38: 329\u2013335.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/hr.2014.110","volume":"37","author":"K Fujisaki","year":"2014","unstructured":"Fujisaki K, Tsuruya K, Nakano T, Taniguchi M, Higashi H, Katafuchi R, Kanai H, Nakayama M, Hirakata H, Kitazono T . Impact of combined losartan\/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension (ILOHA) study investigators. Impact of combined losartan\/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension. Hypertens Res 2014; 37: 993\u2013998.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/hr.2014.114","volume":"37","author":"H Rakugi","year":"2014","unstructured":"Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, Fujimoto G, Azuma K, Shirakawa M, Hanson ME, Fujita KP . Efficacy and safety of losartan 100 mg\/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials. Hypertens Res 2014; 37: 1042\u20131049.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR8","unstructured":"Minister of Health, Labour, and Welfare The results of the 2014 National Health and Nutrition Survey in Japan 2015 in Japanese."},{"key":"BFhr2016120_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1291\/hypres.28.953","volume":"28","author":"Y Ohta","year":"2005","unstructured":"Ohta Y, Tsuchihashi T, Onaka U, Eto K, Tominaga M, Ueno M . Long-term compliance with salt restriction in Japanese hypertensive patients. Hypertens Res 2005; 28: 953\u2013957.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/hr.2014.100","volume":"37","author":"M Sakaki","year":"2014","unstructured":"Sakaki M, Tsuchihashi T, Arakawa K, Fukui H, Kameda W, Tominaga M . Long-term variability of urinary salt excretion and blood pressure in hypertensive patients. Hypertens Res 2014; 37: 939\u2013943.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/10641963.2014.892119","volume":"36","author":"M Sakaki","year":"2014","unstructured":"Sakaki M, Tsuchihashi T, Arakawa K . Characteristics of the hypertensive patients with good and poor compliance to long-term salt restriction. Clin Exp Hypertens 2014; 36: 92\u201396.","journal-title":"Clin Exp Hypertens"},{"key":"BFhr2016120_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/hr.2013.41","volume":"36","author":"H Hasegawa","year":"2013","unstructured":"Hasegawa H, Kanozawa K, Asakura J, Takayanagai K, Komuro O, Fukada H, Tokushima H, Kogure H, Matsuzawa M, Mitarai T . Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB resistance. Hypertens Res 2013; 36: 776\u2013782.","journal-title":"Hypertens Res"},{"key":"BFhr2016120_CR13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","volume":"59","author":"GC Roush","year":"2012","unstructured":"Roush GC, Holford TR, Guddati AK . Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 2012; 59: 1110\u20131117.","journal-title":"Hypertension"},{"key":"BFhr2016120_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.114.05122","volume":"65","author":"RHGO Engberink","year":"2015","unstructured":"Engberink RHGO, Frenkel WJ, van den Bogaard B, Brewster LM, Vogt L, van den Born BJH . Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality. Systematic review and meta-analysis. Hypertension 2015; 65: 1033\u20131040.","journal-title":"Hypertension"},{"key":"BFhr2016120_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.114.05021","volume":"65","author":"GC Roush","year":"2015","unstructured":"Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA . Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone. Antihypertensive and metabolic effects. Hypertension 2015; 65: 1041\u20131046.","journal-title":"Hypertension"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/hr2016120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hr2016120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/hr2016120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:07:15Z","timestamp":1641002835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2016120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFhr2016120"],"URL":"https:\/\/doi.org\/10.1038\/hr.2016.120","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"assertion":[{"value":"24 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TT received funding for clinical research from the MSD KK and honoraria from the MSD KK and Dainippon Sumitomo Pharma. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}